Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2025-12-24 @ 11:46 AM
Study NCT ID:
NCT04512261
Status:
WITHDRAWN
Last Update Posted:
2022-07-01
First Post:
2020-07-28
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Sponsor:
Reva Basho
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-28
First Submit QC Date:
None
Study First Post Date:
2020-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-28
Last Update Post Date:
2022-07-01
Last Update Post Date Type:
ACTUAL